|
|
|
Volumn 19, Issue 11, 2004, Pages 1-3
|
|
Special report: the publication of new evidence and effect on physician prescribing behaviors.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CARDIOVASCULAR AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG UTILIZATION;
EVIDENCE BASED MEDICINE;
FORECASTING;
HEALTH INSURANCE;
HORMONE SUBSTITUTION;
HUMAN;
MARKETING;
MASS COMMUNICATION;
NATIONAL HEALTH INSURANCE;
UNITED STATES;
ANTIHYPERTENSIVE AGENTS;
BLUE CROSS;
BLUE SHIELD;
CARDIOVASCULAR AGENTS;
CLINICAL TRIALS;
DIFFUSION OF INNOVATION;
DRUG UTILIZATION;
EVIDENCE-BASED MEDICINE;
FORECASTING;
HORMONE REPLACEMENT THERAPY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MARKETING;
PHYSICIAN'S PRACTICE PATTERNS;
UNITED STATES;
|
|
EID: 13744258831
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|